Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Gabriele Bergers
Affiliation
VIB-Center for Cancer Biology
ORCID
Career Start Year
1991
Papers
76
H Index
47
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36827979
High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Cancer Cell
2023
37043555
Multiomics and spatial mapping characterizes human CD8<sup>+</sup> T cell states in cancer.
Sci Transl Med
2023
36626867
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loop.
Cancer Cell
2023
35172155
LGL1 binds to Integrin β1 and inhibits downstream signaling to promote epithelial branching in the mammary gland.
Cell Rep
2022
35589749
Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis.
Nat Commun
2022
36423635
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1<sup>+</sup> T lymphocyte niches through a feed-forward loop.
Cancer Cell
2022
36338708
GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide.
Front Oncol
2022
35931821
R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis.
Cell Res
2022
36131018
A cellular hierarchy in melanoma uncouples growth and metastasis.
Nature
2022
36261534
Author Correction: A cellular hierarchy in melanoma uncouples growth and metastasis.
Nature
2022
33462499
The metabolism of cancer cells during metastasis.
Nat Rev Cancer
2021
34484246
High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
Front Immunol
2021
30742781
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis.
Annu Rev Physiol
2019
31572387
Tumors vs. Chronic Wounds: An Immune Cell's Perspective.
Front Immunol
2019
31255690
Peptide-guided nanoparticles for glioblastoma targeting.
J Control Release
2019
29603739
Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.
J Pathol
2018
29935312
The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.
Semin Cancer Biol
2018
30202050
A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma.
Nat Cell Biol
2018
30332627
Where Have All the T Cells Gone?
Immunity
2018
29766399
Consensus guidelines for the use and interpretation of angiogenesis assays.
Angiogenesis
2018
28973887
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Proc Natl Acad Sci U S A
2017
28404866
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
Sci Transl Med
2017
29245888
Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors.
Oncotarget
2017
28396525
Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.
Cold Spring Harb Symp Quant Biol
2016
25770923
Intertwined regulation of angiogenesis and immunity by myeloid cells.
Trends Immunol
2015
26273044
CANCER. Tumor angiogenesis, from foe to friend.
Science
2015
27088132
Glioblastoma: Defining Tumor Niches.
Trends Cancer
2015
25892230
Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.
Cell Rep
2015
24493698
Novel target for peptide-based imaging and treatment of brain tumors.
Mol Cancer Ther
2014
25199993
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
NMR Biomed
2014
24970064
Angiogenesis. Targeting vascular sprouts.
Science
2014
24272355
Escape mechanisms from antiangiogenic therapy: an immune cell's perspective.
Adv Exp Med Biol
2014
23307858
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Clin Cancer Res
2013
24332035
Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.
Cancer Cell
2013
23750318
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.
CNS Oncol
2013
22789536
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.
Cancer Cell
2012
21480238
Tumor microenvironment and progression.
J Surg Oncol
2011
21907924
Asymmetry-defective oligodendrocyte progenitors are glioma precursors.
Cancer Cell
2011
21156288
Non-stem cell origin for oligodendroglioma.
Cancer Cell
2010
19249680
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
Cancer Cell
2009
19690143
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Cancer Res
2009
18359864
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.
Neuro Oncol
2008
19022055
Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors.
Methods Enzymol
2008
18577219
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
BMC Med
2008
18650835
Modes of resistance to anti-angiogenic therapy.
Nat Rev Cancer
2008
18232728
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
PLoS Med
2008
18328425
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.
Cancer Cell
2008
17297464
Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene.
Oncogene
2007
17909053
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Cancer Res
2007
16888086
The bone marrow constitutes a reservoir of pericyte progenitors.
J Leukoc Biol
2006
1 - 50 of 76
Column Actions
Search
Recommended Authors
Mara Gilardi
Institute of Medical Genetics and Pathology.
Career Start Year
2014
Number of shared co-authors
0
Filip Roudnicky
F. Hoffmann-La Roche Ltd.
Career Start Year
2012
Number of shared co-authors
0
Meenu Jain
Georgia Cancer Center, Augusta University
Career Start Year
2011
Number of shared co-authors
0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year
2010
Number of shared co-authors
0
Giorgio Seano
Institut Curie, INSERM U1, CNRS UMR3347, University Paris-Saclay
Career Start Year
2009
Number of shared co-authors
8
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year
2009
Number of shared co-authors
1
Jonas Kloepper
University of Lausanne
Career Start Year
2008
Number of shared co-authors
8
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year
2004
Number of shared co-authors
1
Michael G Ozawa
Stanford University School of Medicine
Career Start Year
2004
Number of shared co-authors
2
Ivy X Chen
Massachusetts General Hospital
Career Start Year
2002
Number of shared co-authors
8
Tuomas Tammela
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
2
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year
2002
Number of shared co-authors
0
Trevor D McKee
University Health Network
Career Start Year
2001
Number of shared co-authors
1
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year
2001
Number of shared co-authors
2
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year
1999
Number of shared co-authors
5
Yuhui Yang
Xuanwu Hospital, Capital Medical University
Career Start Year
1999
Number of shared co-authors
0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year
1996
Number of shared co-authors
7
Jacqueline F Donoghue
University of Melbourne
Career Start Year
1995
Number of shared co-authors
2
Jan Paul Medema
Oncode Institute
Career Start Year
1993
Number of shared co-authors
2
Suyun Huang
Virginia Commonwealth University
Career Start Year
1993
Number of shared co-authors
0
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Career Start Year
1993
Number of shared co-authors
0
Mai Nguyen
University of California Riverside
Career Start Year
1992
Number of shared co-authors
0
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year
1992
Number of shared co-authors
12
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year
1992
Number of shared co-authors
0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
1
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year
1989
Number of shared co-authors
3
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year
1988
Number of shared co-authors
1
Michael Detmar
Institute of Pharmaceutical Sciences, ETH Zurich
Career Start Year
1986
Number of shared co-authors
2
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year
1984
Number of shared co-authors
9
row(s) 1 - 30 of 30
Collaborators
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers
9
Scott R VandenBerg
University of California san francisco
Co-authored papers
6
Diether Lambrechts
Co-authored papers
6
Claudia Petritsch
Co-authored papers
6
William A Weiss
University of California san francisco
Co-authored papers
5
Manish K Aghi
University of California san francisco
Co-authored papers
3
Mitchel S Berger
University of California san francisco
Co-authored papers
3
Anders I Persson
University of California san francisco
Co-authored papers
3
Joanna J Phillips
University of California san francisco
Co-authored papers
3
Michael De Lay
University of California San Francisco (UCSF)
Co-authored papers
2
Arturo Alvarez-Buylla
University of California san francisco
Co-authored papers
2
Charles D James
Co-authored papers
2
Sirpa Jalkanen
Co-authored papers
2
Valerie M Weaver
University of California san francisco
Co-authored papers
2
Daniel A Lim
University of California san francisco
Co-authored papers
2
Arman Jahangiri
Hamadan University of Medical Sciences
Co-authored papers
2
Suzanne B R Jacobs
Co-authored papers
1
Frank B Furnari
University of California San Diego
Co-authored papers
1
Catherine C Park
University of California san francisco
Co-authored papers
1
Carolyn R Bertozzi
Stanford University
Co-authored papers
1
Dolores Hambardzumyan
Co-authored papers
1
James M Barnes
Center for Bioengineering and Tissue Regeneration
Co-authored papers
1
Patrick M Flanigan
Mayo Clinic
Co-authored papers
1
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
1
Jason C Tung
University of California san francisco
Co-authored papers
1
Alexander S Barrett
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Han Liang
MD Anderson Cancer Center
Co-authored papers
1
Kari Alitalo
Wihuri Research Institute
Co-authored papers
1
Ankush Chandra
University of California san francisco
Co-authored papers
1
Joseph F Costello
University of California san francisco
Co-authored papers
1
1 - 30